Related references
Note: Only part of the references are listed.Immunization of Mice with Single PspA Fragments Induces Antibodies Capable of Mediating Complement Deposition on Different Pneumococcal Strains and Cross-Protection
Adriana T. Moreno et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Complement Receptor 1 Expression on Mouse Erythrocytes Mediates Clearance of Streptococcus pneumoniae by Immune Adherence
Jie Li et al.
INFECTION AND IMMUNITY (2010)
Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae
Martina M. Ochs et al.
MICROBIAL PATHOGENESIS (2008)
CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages
Eric Vachon et al.
BLOOD (2007)
PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation
Jie Li et al.
INFECTION AND IMMUNITY (2007)
Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice
Lisa R. Quin et al.
INFECTION AND IMMUNITY (2007)
Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis
Francisco Leon et al.
JOURNAL OF IMMUNOLOGY (2006)
Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes
Jose Yuste et al.
JOURNAL OF IMMUNOLOGY (2006)
Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries
SK Hollingshead et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Lipoprotein PsaA in virulence of Streptococcus pneumoniae:: Surface accessibility and role in protection from superoxide
JW Johnston et al.
INFECTION AND IMMUNITY (2004)
The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection
B Ren et al.
JOURNAL OF IMMUNOLOGY (2004)
Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface
B Ren et al.
INFECTION AND IMMUNITY (2004)
Protective efficacy of pspA (pneumococcal surface protein A)-based DNA vaccines:: contribution of both humoral and cellular immune responses
EN Miyaji et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Activation of CR3-mediated phagocytosis by MSP requires the RON receptor, tyrosine kinase activity, phosphatidylinositol 3-kinase, and protein kinase C ζ
MA Lutz et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Recognition of pneumolysin by toll-like receptor 4 confers resistance to pneumococcal infection
R Malley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae
B Ren et al.
INFECTION AND IMMUNITY (2003)
Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae
M Abeyta et al.
INFECTION AND IMMUNITY (2003)
Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis
U Koedel et al.
JOURNAL OF IMMUNOLOGY (2003)
Pattern recognition receptors: Doubling up for the innate immune response
S Gordon
CELL (2002)
The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice
JS Brown et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Gram-negative bacteria and phagocytic cell interaction mediated by complement receptor 3
J Agramonte-Hevia et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2002)
Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae
P Balachandran et al.
INFECTION AND IMMUNITY (2002)
Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine
HY Kang et al.
INFECTION AND IMMUNITY (2002)
Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection
BP Arulanandam et al.
INFECTION AND IMMUNITY (2001)
Complete genome sequence of a virulent isolate of Streptococcus pneumoniae
H Tettelin et al.
SCIENCE (2001)
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
DE Briles et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Diversity of PspA:: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae
SK Hollingshead et al.
INFECTION AND IMMUNITY (2000)
Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins
AM Berry et al.
INFECTION AND IMMUNITY (2000)
Share Paper
